Iambic Therapeutics, an AI-driven biotech firm, experienced a strong market debut on Nasdaq, with shares rising 16% to $18.50 after a $150 million IPO. The company aims to innovate cancer treatment through its proprietary AI systems and has significant backing from notable inves…
Olema Pharmaceuticals experienced a significant decline in its stock price following AstraZeneca's announcement that its Phase 3 SERENA-4 trial did not meet its primary endpoint.…
Anavex Life Sciences is making strides in its Phase 3 planning for Alzheimer's disease with the FDA, having submitted clinical trial data and reporting a cash position of $118.3 m…
Apnimed is preparing for a $160 million initial public offering on the Nasdaq to support the development of its lead therapy for obstructive sleep apnoea (OSA). The Massachusetts-…
Forte Biosciences experienced a significant share price increase of 39.2% in pre-market trading after Argenx announced a definitive agreement to acquire the biotechnology firm for…
Scribe Therapeutics experienced a significant surge in its stock price, climbing approximately 67% on its first day of trading on the Nasdaq after raising $128.7 million in its in…
Agenus Inc. announced an $85 million private placement aimed at bolstering its balance sheet and supporting its clinical pipeline, leading to a 13% rise in its shares during prema…
Nvidia's venture arm, NVentures, has acquired 833,325 shares in Generate Biomedicines, valued at approximately $10.4 million. Generate is developing an AI-driven platform for drug…
The fasting-mimicking diet (FMD) has emerged as a promising approach to improving metabolic health, supported by recent human studies. This diet allows individuals to experience f…
A new IV hydration spa is offering unapproved stem cell and exosome infusions in a deluxe wellness package, raising eyebrows about the future of beauty and wellness choices.
Brighteon University is set to stream 'Vaccine Education for Mama Bears,' an educational series aimed at empowering parents to make informed vaccination decisions for their childr…
Over 50 bipartisan lawmakers are urging the Trump administration to reconsider a proposed Medicare policy, asserting it could hinder innovation in cancer treatment and patient acc…
While protein is often the focus for muscle building, recent research highlights seven additional nutrients that can significantly enhance muscle growth. This article explores the…
The iShares Biotechnology ETF (IBB) has significantly outperformed the S&P 500 over the past three months, raising questions for investors about the sustainability of this trend.…